Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment

被引:5
|
作者
Zawar, Ifrah [1 ]
Kapur, Jaideep [1 ]
Mattos, Meghan K. [2 ]
Aldridge, Chad M. [1 ]
Manning, Carol [1 ]
Quigg, Mark [1 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22903 USA
[2] Univ Virginia, Sch Nursing, Charlottesville, VA USA
关键词
DATA SET UDS; EPILEPTIFORM ACTIVITY; ALZHEIMER-DISEASE; ONSET EPILEPSY; OLDER-ADULTS; DEMENTIA; TAU; RISK; ETHNICITY; MOUSE;
D O I
10.1212/WNL.0000000000209820
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives Seizures are common in dementia and associated with accelerated cognitive decline. However, the impact of active vs remote seizures on cognition remains understudied. This study aimed to investigate the impact of active vs remote seizures on cognition in people with normal cognition and mild cognitive impairment (MCI). Methods This longitudinal, multicenter cohort is based on National Alzheimer's Coordinating Center data of participants recruited from 39 Alzheimer's Disease Centers in the United States from September 2005 to December 2021. All participants with normal cognition and MCI and at least 2 visits were included. Primary outcome, that is, cognitive decline, was determined using Clinical Dementia Rating (CDR) from (1) normal-to-impaired (CDR >= 0.5) and (2) MCI-to-dementia (CDR >= 1) groups. The effect of active seizures (over the preceding 12 months), remote seizures (previous seizures but none over the preceding 12 months), and no seizures (controls) on cognition was assessed. Subgroups of chronic seizures at enrollment and new-onset seizures were further analyzed. Cox regression models assessed the risk of all-cause MCI and/or dementia. All models were adjusted for age, sex, education, race, hypertension, and diabetes. Results Of the 13,726 participants with normal cognition at enrollment (9,002 [66%] female; median age 71 years), 118 had active seizures and 226 had remote seizures. Of the 11,372 participants with MCI at enrollment (5,605 [49%] female; median age 73 years), 197 had active seizures and 226 had remote seizures. Active seizures were associated with 2.1 times higher risk of cognitive impairment (adjusted hazard ratio [aHR] 2.13, 95% CI 1.60-2.84, p < 0.001) in cognitively healthy adults (median years to decline: active seizures = similar to 1, remote seizures = similar to 3, no seizures = similar to 3) and 1.6 times higher risk of dementia (aHR 1.58, 95% CI 1.24-2.01, p < 0.001) in those with MCI (median years to decline: active seizures = similar to 1, remote seizures = similar to 2, controls = similar to 2). This risk was not observed with remote seizures. Discussion In this study, active seizures but not remote seizures were associated with earlier cognitive decline in both cognitively normal adults and those with MCI, independent of other dementia risk factors. Therefore, early identification and management of seizures may present a path to mitigation of cognitive decline in the aging epileptic population. A limitation is that causality cannot be confirmed in our observational longitudinal study.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment
    Li, Zonghua
    Heckman, Michael G.
    Kanekiyo, Takahisa
    Martens, Yuka A.
    Day, Gregory S.
    Vassilaki, Maria
    Liu, Chia-Chen
    Bennett, David A.
    Petersen, Ronald C.
    Zhao, Na
    Bu, Guojun
    NEUROLOGY, 2022, 98 (20) : E2036 - E2045
  • [22] A Comparison of the Brain Parameters of Thais with Normal Cognition, Mild Cognitive Impairment, and Dementia
    Wisetwongsa, Pariwat
    Piyaselakul, Sitha
    Vichianin, Yudthaphon
    Chiewvit, Pipat
    Rattanabannakit, Chatchawan
    Hunnangkul, Saowalak
    Wongkom, Natthamon
    Dujada, Pathitta
    Senanarong, Vorapun
    BRAIN SCIENCES, 2025, 15 (02)
  • [23] Personality and Transition From Mild Cognitive Impairment to Normal Cognition vs Dementia
    Stephan, Yannick
    Sutin, Angelina R.
    Luchetti, Martina
    Aschwanden, Damaris
    Terracciano, Antonio
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2024, 25 (10)
  • [24] The impact of education on the association between tau deposits and cognition in Mild Cognitive Impairment
    Trombella, S.
    Frisoni, G. B.
    Garibotto, V. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S250 - S250
  • [25] The functional and structural connectomes of telomere length and their association with cognition in mild cognitive impairment
    Yu, Junhong
    Kanchi, Madhu Mathi
    Rawtaer, Iris
    Feng, Lei
    Kumar, Alan Prem
    Kua, Ee-Heok
    Mahendran, Rathi
    CORTEX, 2020, 132 : 29 - 40
  • [26] Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?
    O'Caoimh, Ronan
    Gao, Yang
    Gallagher, Paul Francis
    Eustace, Joesph
    McGlade, Ciara
    Molloy, D. William
    AGE AND AGEING, 2013, 42 (03) : 324 - 330
  • [27] Assessment of cognition in mild cognitive impairment: A comparative study
    Snyder, Peter J.
    Jackson, Colleen E.
    Petersen, Ronald C.
    Khachaturian, Ara S.
    Kaye, Jeffrey
    Albert, Marilyn S.
    Weintraub, Sandra
    ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 338 - 355
  • [28] Cholinergic system function and cognition in mild cognitive impairment
    Haense, Cathleen
    Kalbe, Elke
    Herholz, Karl
    Hohmann, Christoph
    Neumaier, Bernd
    Krais, Roman
    Heiss, Wolf-Dieter
    NEUROBIOLOGY OF AGING, 2012, 33 (05) : 867 - 877
  • [29] Incidence of Mild Cognitive Impairment in the CHS Cognition Study
    Lopez, Oscar
    Becker, James
    Chang, Yue-Fang
    Sweet, Robert
    DeKosky, Steven
    Gach, H. Michael
    Carmichael, Owen
    McDade, Eric
    Kuller, Lewis
    NEUROLOGY, 2012, 78
  • [30] Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people
    del Ser, Teodoro
    Zea, Maria-Ascension
    Valenti, Meritxell
    Olazaran, Javier
    Lopez-Alvarez, Jorge
    Rebollo-Vazquez, Ana
    Avila-Villanueva, Marina
    Frades, Belen
    Medina, Miguel
    Fernandez-Blazquez, Miguel A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (08) : 965 - 974